Bluebird Bio

About:

Bluebird Bio is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.

Website: http://www.bluebirdbio.com

Twitter/X: bluebirdbio

Top Investors: Hercules Capital, RA Capital Management, ARCH Venture Partners, Third Rock Ventures, Forbion Capital Partners

Description:

bluebird bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.